Target intelligence / Profile preview

Innate immune pattern-recognition and danger-sensing pathways (PRR pathways)

Target
PRR pathways
Molecular classification
Receptor, Enzyme, Transcription factor, Signaling pathway, Adaptor protein
01

Overview

The innate immune pattern-recognition and danger-sensing pathways represent the primary sensory apparatus of the host immune system, responsible for detecting and responding to biological threats. These pathways are centered around Pattern Recognition Receptors (PRRs), including Toll-like receptors (TLRs), NOD-like receptors (NLRs), RIG-I-like receptors (RLRs), and cytosolic DNA sensors such as cGAS-STING. PRRs identify conserved microbial motifs known as Pathogen-Associated Molecular Patterns (PAMPs) and endogenous signals of cellular damage called Damage-Associated Molecular Patterns (DAMPs). Activation of these receptors initiates complex signaling cascades that culminate in the production of pro-inflammatory cytokines, chemokines, and interferons, which orchestrate the initial immune response and shape subsequent adaptive immunity. Dysregulation of these pathways is a hallmark of numerous diseases, including chronic inflammatory conditions, autoimmune disorders, and cancer. Consequently, these pathways are major therapeutic targets; agonists are being developed to 'warm up' cold tumors in oncology, while antagonists and inhibitors are explored to treat hyperinflammatory states like sepsis and COVID-19.

Other names
Pattern recognition receptor signalingPAMP and DAMP sensing pathwaysInnate immune sensingDanger-associated molecular pattern sensingInnate immune sensor pathways
02

Mechanism of action

Modulation of pattern recognition receptors (PRRs) to either stimulate innate immune responses for anti-tumor or anti-viral activity, or to inhibit excessive inflammatory signaling in autoimmune and hyperinflammatory conditions.

03

Biological functions

Immune responseInflammationSignal transductionApoptosisAutophagyCell deathAntiviral defense
04

Disease associations

InfectionInflammationAutoimmune diseaseCancerNeurodegenerative diseaseSepsisMetabolic disease
05

Safety considerations

Cytokine stormAutoimmunityImmunosuppressionSystemic inflammatory response syndrome (SIRS)Off-target inflammationInjection site reactions
06

Interacting drugs

Imiquimod

10 more in the full profile.

07

Biomarkers

Interleukin-1 beta (IL-1b)Tumor necrosis factor alpha (TNF-a)Interleukin-6 (IL-6)Type I Interferons (IFN-a/b)C-reactive protein (CRP)CD64ProcalcitoninSerum amyloid A (SAA)

Beyond the preview

Go deeper on Innate immune pattern-recognition and danger-sensing pathways (PRR pathways).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innate immune pattern-recognition and danger-sensing pathways (PRR pathways).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call